4 published verifications about Bogalusa Heart Study Bogalusa Heart Study ×
“The Bogalusa Heart Study was a long-term study that followed children's cardiovascular health into adulthood and found evidence that cardiovascular disease can begin in childhood.”
The evidence strongly supports this description of the Bogalusa Heart Study. It was a long-running longitudinal study that followed children into adulthood, and its autopsy and follow-up findings helped show that atherosclerotic cardiovascular disease processes can start in childhood. The wording is appropriately cautious because it refers to evidence of early disease development, not typical childhood heart attacks.
“About 16,000 children participated in the Bogalusa Heart Study over about 40 years.”
The timeline is broadly plausible, but the headcount is not. Available evidence supports a decades-long study, yet the cited figure of about 16,000 refers to participants overall, not clearly to children alone. More authoritative descriptions place the cohort closer to roughly 12,000–14,000 people, often counting both children and adults.
“Nineteen children died during the Bogalusa Heart Study.”
The evidence does not support the statement that exactly nineteen children died during the Bogalusa Heart Study. Authoritative sources report hundreds of deaths overall and substantial youth autopsy data, but none isolates a count of nineteen child deaths. The claim also conflates participant follow-up with community autopsy research and supplies a precise figure that the sources do not provide.
“In the Bogalusa Heart Study, about 25% of participants reached a healthy weight as adults and about 75% remained overweight or obese as adults.”
The evidence does not support this as a Bogalusa Heart Study finding. Bogalusa research shows that childhood weight often tracks into adulthood, but the cited studies do not establish that roughly 25% reached a healthy adult weight and 75% remained overweight or obese. The closest direct figure in the provided evidence is about 52% becoming non-overweight/obese in a relevant sample, not 25%.